Evidence map›Paper›PMID 36507253›Full record

ReviewFrontiers in bioengineering and biotechnology2022

Recent advances in engineering hydrogels for niche biomimicking and hematopoietic stem cell culturing.

Xiaochan Huang, Yuting Wang, Tianci Wang, Feiqiu Wen, Sixi Liu, Gerile Oudeng

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiaochan HuangDepartment of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Yuting WangDepartment of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Tianci WangDepartment of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Feiqiu WenDepartment of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Sixi LiuDepartment of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Gerile OudengDepartment of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen, Guangdong, China.
Shenzhen Children's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hematopoietic stem cells (HSCs) provide a life-long supply of haemopoietic cells and are indispensable for clinical transplantation in the treatment of malignant hematological diseases. Clinical applications require vast quantities of HSCs with maintained stemness characteristics. Meeting this demand poses often insurmountable challenges for traditional culture methods. Creating a supportive artificial microenvironment for the culture of HSCs, which allows the expansion of the cells while maintaining their stemness, is becoming a new solution for the provision of these rare multipotent HSCs. Hydrogels with good biocompatibility, excellent hydrophilicity, tunable biochemical and biophysical properties have been applied in mimicking the hematopoietic niche for the efficient expansion of HSCs. This review focuses on recent progress in the use of hydrogels in this specialized application. Advanced biomimetic strategies use for the creation of an artificial haemopoietic niche are discussed, advances in combined use of hydrogel matrices and microfluidics, including the emerging organ-on-a-chip technology, are summarized. We also provide a brief description of novel stimulus-responsive hydrogels that are used to establish an intelligent dynamic cell microenvironment. Finally, current challenges and future perspectives of engineering hydrogels for HSC biomedicine are explored.

Indexed as

cell microenvironmenthematopoietic stem cellshydrogelsin vitro expansionniche biomimicking

Identifiers

PMID36507253
PMCPMC9730123
OpenAlexW4309848526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.